Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | HLX02 |
| Trade Name | |
| Synonyms | HLX-02|HLX 02 |
| Drug Descriptions |
HLX02 is a biosimilar to Herceptin (trastuzumab), which potentially reduces growth of ERBB2 (HER2)-expressing tumors (PMID: 38982548). |
| DrugClasses | HER2 (ERBB2) Antibody 79 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| HLX02 | HLX02 | 0 | 0 |
| HLX02 + HLX22 | HLX02 HLX22 | 0 | 0 |